Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer

• Vittoria Lopez,
• Vittoria Lopez,
• H. J. Maximilian Schuh,
• Salahuddin Mirza,
• Salahuddin Mirza,
• Victoria J. Vaaßen,
• Victoria J. Vaaßen,
• Michael S. Schmidt,
• Katharina Sylvester,
• Katharina Sylvester,
• Riham M. Idris,
• Riham M. Idris,
• Christian Renn,
• Christian Renn,
• Laura Schäkel,
• Laura Schäkel,
• Julie Pelletier,
• Jean Sévigny,
• Jean Sévigny,
• Annamaria Naggi,
• Björn Scheffler,
• Sang-Yong Lee,
• Sang-Yong Lee,
• Gerd Bendas,
• Christa E. Müller,
• Christa E. Müller

Affiliations

Vittoria Lopez

Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany

Vittoria Lopez

PharmaCenter Bonn, University of Bonn, Bonn, Germany

H. J. Maximilian Schuh

Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, Bonn, Germany

Salahuddin Mirza

Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany

Salahuddin Mirza

PharmaCenter Bonn, University of Bonn, Bonn, Germany

Victoria J. Vaaßen

Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany

Victoria J. Vaaßen

PharmaCenter Bonn, University of Bonn, Bonn, Germany

Michael S. Schmidt

Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, Bonn, Germany

Katharina Sylvester

Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany

Katharina Sylvester

PharmaCenter Bonn, University of Bonn, Bonn, Germany

Riham M. Idris

Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany

Riham M. Idris

PharmaCenter Bonn, University of Bonn, Bonn, Germany

Christian Renn

Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany

Christian Renn

PharmaCenter Bonn, University of Bonn, Bonn, Germany

Laura Schäkel

Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany

Laura Schäkel

PharmaCenter Bonn, University of Bonn, Bonn, Germany

Julie Pelletier

Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada

Jean Sévigny

Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada

Jean Sévigny

Départment de Microbiologie-Infectiologie et d’Immunologie, Faculté de Médecine, Université Laval, Quebec, QC, Canada

Annamaria Naggi

Institute for Chemical and Biochemical Research “G. Ronzoni”, Milan, Italy

Björn Scheffler

DKFZ Division Translational Neurooncology at the West German Cancer Center (WTZ), DKTK Partner site, University Hospital Essen and German Cancer Research Center, Heidelberg, Germany

Sang-Yong Lee

Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany

Sang-Yong Lee

PharmaCenter Bonn, University of Bonn, Bonn, Germany

Gerd Bendas

Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, Bonn, Germany

Christa E. Müller

Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany

Christa E. Müller

PharmaCenter Bonn, University of Bonn, Bonn, Germany